HRT Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-36,317
| Closed | -$2.57M | – | 2332 |
|
|
2025
Q1 | $2.57M | Buy |
36,317
+14,996
| +70% | +$1.06M | 0.02% | 591 |
|
|
2024
Q4 | $1.4M | Buy |
+21,321
| New | +$1.4M | 0.01% | 778 |
|
|
2024
Q2 | – | Sell |
-43,024
| Closed | -$3.76M | – | 2074 |
|
|
2024
Q1 | $3.76M | Sell |
43,024
-6,050
| -12% | -$528K | 0.02% | 343 |
|
|
2023
Q4 | $4.73M | Buy |
+49,074
| New | +$4.73M | 0.03% | 303 |
|
|
2023
Q2 | – | Sell |
-19,515
| Closed | -$1.9M | – | 2298 |
|
|
2023
Q1 | $1.9M | Buy |
+19,515
| New | +$1.9M | 0.02% | 592 |
|
|
2022
Q3 | – | Sell |
-7,385
| Closed | -$611K | – | 2629 |
|
|
2022
Q2 | $611K | Buy |
7,385
+4,449
| +152% | +$368K | 0.01% | 1308 |
|
|
2022
Q1 | $226K | Buy |
+2,936
| New | +$226K | ﹤0.01% | 2169 |
|
|
2021
Q3 | – | Sell |
-127,030
| Closed | -$10.6M | – | 3018 |
|
|
2021
Q2 | $10.6M | Buy |
+127,030
| New | +$10.6M | 0.1% | 167 |
|
|
2021
Q1 | – | Sell |
-131,636
| Closed | -$11.5M | – | 2483 |
|
|
2020
Q4 | $11.5M | Buy |
+131,636
| New | +$11.5M | 0.23% | 70 |
|
|
2019
Q4 | – | Sell |
-4,343
| Closed | -$292K | – | 1114 |
|
|
2019
Q3 | $292K | Buy |
4,343
+1,611
| +59% | +$108K | 0.01% | 849 |
|
|
2019
Q2 | $233K | Buy |
+2,732
| New | +$233K | 0.01% | 578 |
|
|
2015
Q4 | – | Sell |
-1,944
| Closed | -$204K | – | 69 |
|
|
2015
Q3 | $204K | Buy |
+1,944
| New | +$204K | 0.17% | 75 |
|